# Plegridy Observational Program

> **NCT02230969** · — · COMPLETED · sponsor: **Biogen** · enrollment: 1208 (actual)

## Conditions studied

- Relapsing Forms of Multiple Sclerosis

## Interventions

- **DRUG:** peginterferon beta-1a

## Key facts

- **NCT ID:** NCT02230969
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-12
- **Primary completion:** 2022-01-20
- **Final completion:** 2022-01-20
- **Target enrollment:** 1208 (ACTUAL)
- **Last updated:** 2022-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02230969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02230969, "Plegridy Observational Program". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02230969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*